255 related articles for article (PubMed ID: 11972262)
21. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.
Gurbel PA; Bliden KP; Zaman KA; Yoho JA; Hayes KM; Tantry US
Circulation; 2005 Mar; 111(9):1153-9. PubMed ID: 15738352
[TBL] [Abstract][Full Text] [Related]
22. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
Kawamura M; Imura Y; Moriya N; Kita S; Fukushi H; Sugihara H; Nishikawa K; Terashita Z
J Pharmacol Exp Ther; 1996 Apr; 277(1):502-10. PubMed ID: 8613960
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
[TBL] [Abstract][Full Text] [Related]
24. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
[TBL] [Abstract][Full Text] [Related]
25. Novel platelet inhibitors.
Bennett JS
Annu Rev Med; 2001; 52():161-84. PubMed ID: 11160773
[TBL] [Abstract][Full Text] [Related]
26. Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.
Wilson JM; Ferguson JJ
Clin Cardiol; 1999 Nov; 22(11):687-98. PubMed ID: 10554682
[TBL] [Abstract][Full Text] [Related]
27. Aspirin in patients with coronary artery disease: is it simply irresistible?
Nair GV; Davis CJ; McKenzie ME; Lowry DR; Serebruany VL
J Thromb Thrombolysis; 2001 Apr; 11(2):117-26. PubMed ID: 11406726
[No Abstract] [Full Text] [Related]
28. Effect of combined administration of clopidogrel and lysine acetylsalicylate versus clopidogrel and aspirin on platelet aggregation and activated GPIIb/IIIa expression in healthy volunteers.
Majluf-Cruz A; Chavez-Ochoa AR; Majluf-Cruz K; Coria-Ramirez E; Pineda Del Aguila I; Treviño-Perez S; Matías-Aguilar L; López-Armenta JC; Corona de la Peña N
Platelets; 2006 Mar; 17(2):105-7. PubMed ID: 16421012
[TBL] [Abstract][Full Text] [Related]
29. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
[TBL] [Abstract][Full Text] [Related]
30. Clopidogrel in interventional cardiology: questions answered and questions remaining.
Nikhil JY; Radhakrishnan S; Paradiso-Hardy FL; Cohen EA
Can J Cardiol; 2002 Jul; 18(7):739-48. PubMed ID: 12167961
[TBL] [Abstract][Full Text] [Related]
31. Ticlopidine and clopidogrel.
Quinn MJ; Fitzgerald DJ
Circulation; 1999 Oct; 100(15):1667-72. PubMed ID: 10517740
[TBL] [Abstract][Full Text] [Related]
32. Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease.
Mueller T; Haltmayer M; Poelz W; Haidinger D
Vasc Endovascular Surg; 2003; 37(2):117-23. PubMed ID: 12669143
[TBL] [Abstract][Full Text] [Related]
33. Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy.
Hiatt WR
J Intern Med; 2002 Mar; 251(3):193-206. PubMed ID: 11886478
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet agents in stroke prevention. combination therapy: present and future.
Weksler BB
Cerebrovasc Dis; 2000; 10 Suppl 5():41-8. PubMed ID: 11096182
[TBL] [Abstract][Full Text] [Related]
35. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation.
Rupprecht HJ; Darius H; Borkowski U; Voigtländer T; Nowak B; Genth S; Meyer J
Circulation; 1998 Mar; 97(11):1046-52. PubMed ID: 9531251
[TBL] [Abstract][Full Text] [Related]
36. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel.
Sibbing D; von Beckerath O; Schömig A; Kastrati A; von Beckerath N
J Thromb Haemost; 2006 Dec; 4(12):2566-8. PubMed ID: 16938125
[No Abstract] [Full Text] [Related]
38. The Antiplatelet Effect of Clopidogrel Decreases With Patient Age.
Xhelili E; Eichelberger B; Kopp CW; Koppensteiner R; Panzer S; Gremmel T
Angiology; 2016 Nov; 67(10):902-908. PubMed ID: 26861857
[TBL] [Abstract][Full Text] [Related]
39. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.
Dai H; Chen J; Tao Q; Zhu J; Zhang F; Zheng L; Qiu Y
Postgrad Med J; 2003 Sep; 79(935):522-6. PubMed ID: 13679549
[TBL] [Abstract][Full Text] [Related]
40. [New antiaggregants and their importance for the practitioner].
Tsakiris DA
Ther Umsch; 2003 Jan; 60(1):24-6. PubMed ID: 12638474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
